image

Authoritative Independent Monthly Share Selections Using Technical & Fundamental Analysis

Latest issue now available

Essentra - Trading update drives chart breakout

February 2022

Investing in shares may lose you all or some of your money. Past performance is no indication of future performance. Some of the shares recommended here may be small company shares, which can be relatively illiquid and hard to trade and this makes such shares more risky than other investments.

  • Epic Code:
  • ESNT
  • Price:
  • 350p
In a pleasing update Essentra announced Q4 like-for-like sales grew 12.7% (+11.1% ahead of 2019) with all divisions growing. The group has managed supply chains very well with price rises offsetting cost inflation and order intake has remained strong. As a result EBITDA guidance is unchanged. The highlight was Components (like-for-like sales +18.5%) while Packaging returned to growth (+1.1%) driven by positive pricing and a pick-up in the key US & EU healthcare markets. Despite tough comparatives, Filters grew 22.3%. Meanwhile, the Strategic Review is progressing well and is expected to report back in Q2 ’22 at the earliest. With the shares having broken out, I am a buyer. ...

To access our archive of articles and to receive current issues you need to subscribe.

Subscribe now

Already a subscriber? Login

With small companies there is an above average degree of risk compared to buying blue chips. Please be aware that we have not assessed the suitability of any of these investments for you. The newsletter simply states a personal view and diarises the editor’s investment decisions. Please speak to your stockbroker or other qualified individual to ascertain whether any of these companies mentioned would form useful additions to your own portfolios. Past performance is no indication of future success.

All material on this website is protected by copyright. You may use Information retrieved from the www.scsw.co.uk website for your own personal non-commercial use which means that you may not sell or copy this information to any third party without prior written consent. ISSN 1358-183X

author